| Literature DB >> 24088582 |
Maria I Klapa1, Kalliopi Tsafou, Evangelos Theodoridis, Athanasios Tsakalidis, Nicholas K Moschonas.
Abstract
BACKGROUND: Understanding the topology and dynamics of the human protein-protein interaction (PPI) network will significantly contribute to biomedical research, therefore its systematic reconstruction is required. Several meta-databases integrate source PPI datasets, but the protein node sets of their networks vary depending on the PPI data combined. Due to this inherent heterogeneity, the way in which the human PPI network expands via multiple dataset integration has not been comprehensively analyzed. We aim at assembling the human interactome in a global structured way and exploring it to gain insights of biological relevance.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24088582 PMCID: PMC4015887 DOI: 10.1186/1752-0509-7-96
Source DB: PubMed Journal: BMC Syst Biol ISSN: 1752-0509
The size of the reconstructed direct PPI network for the manually reviewed human “complete” proteome
| 20242 | N/A | N/A | N/A | |
| 9303 | 37152 | 19267 | 1.93 | |
| 6666 | 19425 | 1598 | 12.15 | |
| 6102 | 16147 | 2398 | 6.73 | |
| 1795 | 2609 | 1180 | 2.21 | |
| 9265 | 42647 | 13818 | 3.08 | |
The size of the reconstructed network is compared to the size of the normalized to the UniProt identifier level source PPI datasets for the defined reference protein set. N/A: not applicable.
(1)members of the UniProtKB manually reviewed human “complete” proteome.
(2)between members of the UniProtKB manually reviewed human “complete” proteome.
Figure 1Source of data in the integrated PICKLE PPI dataset.
Figure 2The fractions of PICKLE UniProt identifiers (A) and PPIs (B) contributed from combinations of source datasets. The common contributions for the nodes and the edges of the integrated PPI network from all five source datasets constitute 8.7% and 0.2% of the total, respectively. Only the values of the larger than 3% fractions are shown with the exception of the unique contributions from each individual source dataset, for which all fractions are indicated.
Figure 3The PICKLE reference fraction contributed from source datasets (A) and the reference incorporation rate in the datasets (B). Only 8 common references between the five datasets were identified, confirming that they incorporate knowledge from different studies. In (A), only the values of the larger than 3% fractions are shown with the exception of the unique contributions from each individual source dataset, for which all fractions are indicated.
Figure 4Distribution of PPIs per reference (A) and supporting references per PPI (B) in PICKLE.
The characteristics of the integrated PPI network
| Number of Nodes | 11827 |
| Isolated Nodes (homodimers) | 114 |
| Connected components | 174 (i.e.: 1 cluster of 11577 nodes, 114 homodimers, 46 heterodimers,13 isolated of 3 or 4 nodes) |
| Number of self-loops | 2715 (i.e.: 2601 nodes having interactions with other proteins as well, and 114 isolated homodimers) |
| Network radius | 1 |
| Network diameter | 12 |
| Characteristic Path Length | 3.691 |
| Average Number of Neighbors | 12.387 |
| Shortest Paths | 95% |
| Clustering Coefficient | 0.127 |
| Network Density | 0.001 |
| Network Centralization | 0.093 |
| Network Heterogeneity | 2.193 |
(1)Detailed description for every characteristic can be found in http://med.bioinf.mpi-inf.mpg.de/netanalyzer/help/2.6.1/index.html.
(2)Determined using the network analysis tool of Cytoscape (2.8.2).
Figure 5The distribution of direct interactions for the UniProt identifiers in the PICKLE network. The red line indicates the power-law fit (logarithmic scale); the related equation and R2 correlation are also shown. UniProt identifier P0CG48 (Polyubiquitin, UBC) is identified with the largest number of interactions, i.e. 1112; note the deviation of this UniProt identifier degree from the power-law fit.
The 16 UniProt identifiers with more than 300 interactions in the integrated PPI network
| P0CG48 | UBC_HUMAN | UBC | Polyubiquitin-C [Cleaved into: Ubiquitin] | 1112 |
| P04637 | P53_HUMAN | TP53 | Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53) | 476 |
| P63104 | 1433Z_HUMAN | YWHAZ | 14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1) | 471 |
| P01106 | MYC_HUMAN | MYC | Myc proto-oncogene protein (Class E basic helix-loop-helix protein 39) (bHLHe39) (Proto-oncogene c-Myc) (Transcription factor p64) | 453 |
| Q9Y4K3 | TRAF6_HUMAN | TRAF6 | TNF receptor-associated factor 6 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRAF6) (Interleukin-1 signal transducer) (RING finger protein 85) | 424 |
| Q13547 | HDAC1_HUMAN | HDAC1 | Histone deacetylase 1 (HD1) (EC 3.5.1.98) | 353 |
| P12931 | SRC_HUMAN | SRC | Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src) | 351 |
| P62993 | GRB2_HUMAN | GRB2 | Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3 adapter GRB2) | 341 |
| Q14164 | IKKE_HUMAN | IKBKE | Inhibitor of nuclear factor kappa-B kinase subunit epsilon (I-kappa-B kinase epsilon) (IKK-E) (IKK-epsilon) (IkBKE) (EC 2.7.11.10) (Inducible I kappa-B kinase) (IKK-i) | 338 |
| P61981 | 1433G_HUMAN | YWHAG | 14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed] | 335 |
| Q09472 | EP300_HUMAN | EP300 | Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) | 331 |
| Q9UQL6 | HDAC5_HUMAN | HDAC5 | Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Antigen NY-CO-9) | 324 |
| P00533 | EGFR_HUMAN | EGFR | Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) | 313 |
| P03372 | ESR1_HUMAN | ESR1 | Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) | 312 |
| P27348 | 1433T_HUMAN | YWHAQ | 14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1) | 311 |
| Q9Y6K9 | NEMO_HUMAN | IKBKG | NF-kappa-B essential modulator (NEMO) (FIP-3) (IkB kinase-associated protein 1) (IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma) (I-kappa-B kinase subunit gamma) (IKK-gamma) (IKKG) (IkB kinase subunit gamma) (NF-kappa-B essential modifier) | 304 |